Pancuronium in caesarean section and its placental transfer

Area of Science:

• Anesthesiology
• Obstetrics
• Pharmacology

Background:

• Pancuronium bromide is a neuromuscular blocking agent used in anesthesia.
• Repeat Cesarean sections require careful anesthetic management to ensure maternal and fetal safety.

Purpose of the Study:

• To evaluate the fetal safety and efficacy of pancuronium bromide in repeat Cesarean sections.
• To compare the effects of pancuronium bromide alone versus a combination with suxamethonium on fetal exposure and neonatal condition.

Main Methods:

• A study involving 49 patients undergoing repeat elective Cesarean sections.
• Measurement of pancuronium bromide concentrations in umbilical venous or arterial blood samples.
• Assessment of neonatal condition based on standard clinical parameters.

Main Results:

• Pancuronium bromide was detected in fetal blood regardless of the administration protocol.
• No detrimental effects on the fetus were observed at the measured concentrations.
• Using suxamethonium before pancuronium bromide led to reduced pancuronium dosage, shorter induction-delivery times, and improved neonatal condition.

Conclusions:

• Pancuronium bromide can be safely used in repeat Cesarean sections.
• Pre-administration of suxamethonium optimizes pancuronium bromide use, reducing fetal exposure and enhancing neonatal outcomes.